Drugs / M0002
last change Dec 2007 re-read 3 minutes ago

M0002

Developed for
cirrhosis of liver

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 2 NCT01179607 Comparator Jun → Dec 2007 cirrhosis of liver Movetis Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as M0002 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01179607 ↗
Action Inhibit “antagonist of the vasopressin V2 receptor inhibits vasopressin-induced water reabsorption from the kidney” NCT01179607 ↗
Route Oral “M0002, an orally active” NCT01179607 ↗